Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients.

Autor: Marcisz-Grzanka, Katarzyna¹ (AUTHOR) katarzyna.marcisz-grzanka@nio.gov.pl, Kotowicz, Beata² (AUTHOR) beata.kotowicz@nio.gov.pl, Nowak, Aleksandra³ (AUTHOR) aleksandra.nowak2@nio.gov.pl, Winiarek, Mariola¹ (AUTHOR) agnieszka.kolasinska-cwikla@nio.gov.pl, Fuksiewicz, Malgorzata² (AUTHOR) malgorzata.fuksiewicz@nio.gov.pl, Kowalska, Maria² (AUTHOR) maria.kowalska@nio.gov.pl, Tysarowski, Andrzej³ (AUTHOR) andrzej.tysarowski@nio.gov.pl, Olesinski, Tomasz⁴ (AUTHOR) tomasz.olesinski@nio.gov.pl, Palucki, Jakub⁵ (AUTHOR) jakub.palucki@nio.gov.pl, Sulkowska, Urszula⁶ (AUTHOR) urszula.sulkowska@nio.gov.pl, Kolasinska-Cwikla, Agnieszka¹ (AUTHOR), Wyrwicz, Lucjan Stanislaw¹ (AUTHOR) katarzyna.marcisz-grzanka@nio.gov.pl

Publikováno v: Cancers. Feb2024, Vol. 16 Issue 4, p757. 21p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and safety of FLOT regimen vs DCF, FOLFOX, and ECF regimens as perioperative chemotherapy treatments for resectable gastric cancer patients; a report from the middle east.

Autor: Farrokhi, Pegah¹ (AUTHOR), Sadeghi, Alireza² (AUTHOR), Sharifi, Mehran² (AUTHOR), Riechelmann, Rachel³ (AUTHOR), Moghaddas, Azadeh⁴ (AUTHOR)

Publikováno v: Research in Pharmaceutical Sciences. Dec2022, Vol. 17 Issue 6, p621-634. 14p.

XLOT regimen instead of FLOT regimen in the primary treatment for patients with locally advanced and metastatic gastric cancer.

Autor: Işık, Deniz¹ (AUTHOR), Koca, Doğan¹ (AUTHOR)

Publikováno v: Journal of Cancer Research & Therapeutics. 2023 Suppl 2, Vol. 19, p781-785. 5p.

A fatal case of 5-FU toxicity despite dose adjustment in a patient with a partial DPD deficiency receiving the FLOT regimen.

Autor: Zaanan A; Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, Assistance publique - Hôpitaux de Paris, Université Paris Cité, Paris, France; Centre de Recherche des Cordeliers, INSERM UMRS1138, CNRS, Sorbonne Université, USPC, Université de Paris Cité, SIRIC CARPEM, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC 5096, 75006 Paris, France. Electronic address: aziz.zaanan@aphp.fr., Pallet N; Centre de Recherche des Cordeliers, INSERM UMRS1138, CNRS, Sorbonne Université, USPC, Université de Paris Cité, SIRIC CARPEM, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC 5096, 75006 Paris, France; Department of Clinical Chemistry, Georges Pompidou European Hospital, Assistance publique - Hôpitaux de Paris, Université Paris Cité, Paris, France., Narjoz C; Centre de Recherche des Cordeliers, INSERM UMRS1138, CNRS, Sorbonne Université, USPC, Université de Paris Cité, SIRIC CARPEM, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC 5096, 75006 Paris, France; Department of Clinical Chemistry, Georges Pompidou European Hospital, Assistance publique - Hôpitaux de Paris, Université Paris Cité, Paris, France., Loriot MA; Centre de Recherche des Cordeliers, INSERM UMRS1138, CNRS, Sorbonne Université, USPC, Université de Paris Cité, SIRIC CARPEM, Equipe Labellisée Ligue Nationale Contre le Cancer, CNRS SNC 5096, 75006 Paris, France; Department of Clinical Chemistry, Georges Pompidou European Hospital, Assistance publique - Hôpitaux de Paris, Université Paris Cité, Paris, France., Hafliger É; Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, Assistance publique - Hôpitaux de Paris, Université Paris Cité, Paris, France.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Jul; Vol. 205, pp. 114102. Date of Electronic Publication: 2024 May 06.